These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 34357961)

  • 41. Astrocyte transduction is required for rescue of behavioral phenotypes in the YAC128 mouse model with AAV-RNAi mediated HTT lowering therapeutics.
    Stanek LM; Bu J; Shihabuddin LS
    Neurobiol Dis; 2019 Sep; 129():29-37. PubMed ID: 31042572
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
    Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
    J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular Pathogenesis in Huntington's Disease.
    Illarioshkin SN; Klyushnikov SA; Vigont VA; Seliverstov YA; Kaznacheyeva EV
    Biochemistry (Mosc); 2018 Sep; 83(9):1030-1039. PubMed ID: 30472941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of mutant and total huntingtin expression in Huntington's disease murine models.
    Fodale V; Pintauro R; Daldin M; Altobelli R; Spiezia MC; Bisbocci M; Macdonald D; Bresciani A
    Sci Rep; 2020 Dec; 10(1):22137. PubMed ID: 33335120
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preventing formation of toxic N-terminal huntingtin fragments through antisense oligonucleotide-mediated protein modification.
    Evers MM; Tran HD; Zalachoras I; Meijer OC; den Dunnen JT; van Ommen GJ; Aartsma-Rus A; van Roon-Mom WM
    Nucleic Acid Ther; 2014 Feb; 24(1):4-12. PubMed ID: 24380395
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Biology of Huntingtin.
    Saudou F; Humbert S
    Neuron; 2016 Mar; 89(5):910-26. PubMed ID: 26938440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Huntingtin protein: A new option for fixing the Huntington's disease countdown clock.
    Caterino M; Squillaro T; Montesarchio D; Giordano A; Giancola C; Melone MAB
    Neuropharmacology; 2018 Jun; 135():126-138. PubMed ID: 29526547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of differentially expressed genes and regulatory relationships in Huntington's disease by bioinformatics analysis.
    Dong X; Cong S
    Mol Med Rep; 2018 Mar; 17(3):4317-4326. PubMed ID: 29328442
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Huntington's Disease: Relationship Between Phenotype and Genotype.
    Sun YM; Zhang YB; Wu ZY
    Mol Neurobiol; 2017 Jan; 54(1):342-348. PubMed ID: 26742514
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Targeting mutant huntingtin for the development of disease-modifying therapy.
    Appl T; Kaltenbach L; Lo DC; Terstappen GC
    Drug Discov Today; 2012 Nov; 17(21-22):1217-23. PubMed ID: 22772050
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Post-translational modifications clustering within proteolytic domains decrease mutant huntingtin toxicity.
    Arbez N; Ratovitski T; Roby E; Chighladze E; Stewart JC; Ren M; Wang X; Lavery DJ; Ross CA
    J Biol Chem; 2017 Nov; 292(47):19238-19249. PubMed ID: 28972180
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Elimination of huntingtin in the adult mouse leads to progressive behavioral deficits, bilateral thalamic calcification, and altered brain iron homeostasis.
    Dietrich P; Johnson IM; Alli S; Dragatsis I
    PLoS Genet; 2017 Jul; 13(7):e1006846. PubMed ID: 28715425
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generation of New Isogenic Models of Huntington's Disease Using CRISPR-Cas9 Technology.
    Dabrowska M; Ciolak A; Kozlowska E; Fiszer A; Olejniczak M
    Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32182692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease models.
    Hegde RN; Chiki A; Petricca L; Martufi P; Arbez N; Mouchiroud L; Auwerx J; Landles C; Bates GP; Singh-Bains MK; Dragunow M; Curtis MA; Faull RL; Ross CA; Caricasole A; Lashuel HA
    EMBO J; 2020 Sep; 39(17):e104671. PubMed ID: 32757223
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Lowering Mutant Huntingtin Using Tricyclo-DNA Antisense Oligonucleotides As a Therapeutic Approach for Huntington's Disease.
    Imbert M; Blandel F; Leumann C; Garcia L; Goyenvalle A
    Nucleic Acid Ther; 2019 Oct; 29(5):256-265. PubMed ID: 31184975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Silencing mutant huntingtin by adeno-associated virus-mediated RNA interference ameliorates disease manifestations in the YAC128 mouse model of Huntington's disease.
    Stanek LM; Sardi SP; Mastis B; Richards AR; Treleaven CM; Taksir T; Misra K; Cheng SH; Shihabuddin LS
    Hum Gene Ther; 2014 May; 25(5):461-74. PubMed ID: 24484067
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beta catenin is regulated by its subcellular distribution and mutant huntingtin status in Huntington's disease cell STHdhQ111/HdhQ111.
    Ghatak S; Raha S
    Biochem Biophys Res Commun; 2018 Sep; 503(1):359-364. PubMed ID: 29894684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neurobiology of Huntington's Disease.
    De Souza RA; Leavitt BR
    Curr Top Behav Neurosci; 2015; 22():81-100. PubMed ID: 25205327
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model.
    van Hagen M; Piebes DGE; de Leeuw WC; Vuist IM; van Roon-Mom WMC; Moerland PD; Verschure PJ
    BMC Genomics; 2017 May; 18(1):373. PubMed ID: 28499347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Mutant Huntingtin Is Cleared from the Brain via Active Mechanisms in Huntington Disease.
    Caron NS; Banos R; Yanick C; Aly AE; Byrne LM; Smith ED; Xie Y; Smith SEP; Potluri N; Findlay Black H; Casal L; Ko S; Cheung D; Kim H; Seong IS; Wild EJ; Song JJ; Hayden MR; Southwell AL
    J Neurosci; 2021 Jan; 41(4):780-796. PubMed ID: 33310753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.